chrX-100665569-C-A

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_014467.3(SRPX2):​c.693C>A​(p.His231Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000203 in 1,210,397 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 84 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00020 ( 0 hom., 6 hem., cov: 23)
Exomes 𝑓: 0.00020 ( 0 hom. 78 hem. )

Consequence

SRPX2
NM_014467.3 missense

Scores

17

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:6

Conservation

PhyloP100: -2.61

Publications

1 publications found
Variant links:
Genes affected
SRPX2 (HGNC:30668): (sushi repeat containing protein X-linked 2) This gene encodes a secreted protein that contains three sushi repeat motifs. The encoded protein may play a role in the development of speech and language centers in the brain. This protein may also be involved in angiogenesis. Mutations in this gene are the cause of bilateral perisylvian polymicrogyria, rolandic epilepsy, speech dyspraxia and cognitive disability. [provided by RefSeq, May 2010]
SRPX2 Gene-Disease associations (from GenCC):
  • rolandic epilepsy-speech dyspraxia syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • polymicrogyria, bilateral perisylvian, X-linked
    Inheritance: XL Classification: LIMITED Submitted by: G2P
  • rolandic epilepsy, intellectual disability, and speech dyspraxia, X-linked
    Inheritance: XL Classification: LIMITED, NO_KNOWN Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.010327548).
BP6
Variant X-100665569-C-A is Benign according to our data. Variant chrX-100665569-C-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 198562.
BS2
High AC in GnomAd4 at 22 XL,AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SRPX2NM_014467.3 linkc.693C>A p.His231Gln missense_variant Exon 7 of 11 ENST00000373004.5 NP_055282.1 O60687

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SRPX2ENST00000373004.5 linkc.693C>A p.His231Gln missense_variant Exon 7 of 11 1 NM_014467.3 ENSP00000362095.3 O60687

Frequencies

GnomAD3 genomes
AF:
0.000196
AC:
22
AN:
112205
Hom.:
0
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000975
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000301
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000355
AC:
65
AN:
183066
AF XY:
0.000325
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00194
Gnomad NFE exome
AF:
0.000405
Gnomad OTH exome
AF:
0.000221
GnomAD4 exome
AF:
0.000204
AC:
224
AN:
1098192
Hom.:
0
Cov.:
32
AF XY:
0.000215
AC XY:
78
AN XY:
363546
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
26401
American (AMR)
AF:
0.00
AC:
0
AN:
35207
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19385
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30206
South Asian (SAS)
AF:
0.00
AC:
0
AN:
54145
European-Finnish (FIN)
AF:
0.00131
AC:
53
AN:
40534
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4137
European-Non Finnish (NFE)
AF:
0.000191
AC:
161
AN:
842082
Other (OTH)
AF:
0.000217
AC:
10
AN:
46095
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
12
24
35
47
59
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000196
AC:
22
AN:
112205
Hom.:
0
Cov.:
23
AF XY:
0.000175
AC XY:
6
AN XY:
34371
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
30886
American (AMR)
AF:
0.00
AC:
0
AN:
10622
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2653
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3587
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2661
European-Finnish (FIN)
AF:
0.000975
AC:
6
AN:
6152
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
239
European-Non Finnish (NFE)
AF:
0.000301
AC:
16
AN:
53216
Other (OTH)
AF:
0.00
AC:
0
AN:
1505
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000238
Hom.:
14
Bravo
AF:
0.0000793
TwinsUK
AF:
0.00
AC:
0
ALSPAC
AF:
0.000346
AC:
1
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000149
AC:
1
ExAC
AF:
0.000305
AC:
37
EpiCase
AF:
0.000273
EpiControl
AF:
0.000119

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:6
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:3
-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Mar 12, 2015
Eurofins Ntd Llc (ga)
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Nov 18, 2020
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Aug 12, 2016
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Rolandic epilepsy, intellectual disability, and speech dyspraxia, X-linked Benign:1
May 07, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

SRPX2-related disorder Benign:1
Mar 04, 2022
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.083
BayesDel_addAF
Benign
-0.80
T
BayesDel_noAF
Benign
-1.0
CADD
Benign
1.1
DANN
Benign
0.80
DEOGEN2
Benign
0.035
T;.
FATHMM_MKL
Benign
0.051
N
LIST_S2
Benign
0.43
T;T
M_CAP
Benign
0.0025
T
MetaRNN
Benign
0.010
T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
-0.28
N;.
PhyloP100
-2.6
PrimateAI
Benign
0.35
T
PROVEAN
Benign
0.25
N;.
REVEL
Benign
0.035
Sift
Benign
0.29
T;.
Sift4G
Benign
0.22
T;.
Polyphen
0.0
B;.
Vest4
0.12
MutPred
0.63
Loss of glycosylation at S230 (P = 0.1011);.;
MVP
0.17
MPC
0.16
ClinPred
0.043
T
GERP RS
-4.4
Varity_R
0.059
gMVP
0.24
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs142719253; hg19: chrX-99920566; API